Cargando…
Direct Detection of Glycated Human Serum Albumin and Hyperglycosylated IgG3 in Serum, by MALDI-ToF Mass Spectrometry, as a Predictor of COVID-19 Severity
The prefusion spike protein of SARS-CoV-2 binds advanced glycation end product (AGE)-glycated human serum albumin (HSA) and a higher mass (hyperglycosylated/glycated) immunoglobulin (Ig) G3, as determined by matrix assisted laser desorption mass spectrometry (MALDI-ToF). We set out to investigate if...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601263/ https://www.ncbi.nlm.nih.gov/pubmed/36292212 http://dx.doi.org/10.3390/diagnostics12102521 |
_version_ | 1784817017319063552 |
---|---|
author | Iles, Ray K. Iles, Jason K. Lacey, Jonathan Gardiner, Anna Zmuidinaite, Raminta |
author_facet | Iles, Ray K. Iles, Jason K. Lacey, Jonathan Gardiner, Anna Zmuidinaite, Raminta |
author_sort | Iles, Ray K. |
collection | PubMed |
description | The prefusion spike protein of SARS-CoV-2 binds advanced glycation end product (AGE)-glycated human serum albumin (HSA) and a higher mass (hyperglycosylated/glycated) immunoglobulin (Ig) G3, as determined by matrix assisted laser desorption mass spectrometry (MALDI-ToF). We set out to investigate if the total blood plasma of patients who had recovered from acute respiratory distress syndrome (ARDS) as a result of COVID-19, contained more glycated HSA and higher mass (glycosylated/glycated) IgG3 than those with only clinically mild or asymptomatic infections. A direct serum dilution, and disulphide bond reduction, method was developed and applied to plasma samples from SARS-CoV-2 seronegative (n = 30) and seropositive (n = 31) healthcare workers (HCWs) and 38 convalescent plasma samples from patients who had been admitted with acute respiratory distress (ARDS) associated with COVID-19. Patients recovering from COVID-19 ARDS had significantly higher mass AGE-glycated HSA and higher mass IgG3 levels. This would indicate that increased levels and/or ratios of hyper-glycosylation (probably terminal sialic acid) IgG3 and AGE glycated HSA may be predisposition markers for the development of COVID-19 ARDS as a result of SARS-CoV2 infection. Furthermore, rapid direct analysis of serum/plasma samples by MALDI-ToF for such humoral immune correlates of COVID-19 presents a feasible screening technology for the most at risk; regardless of age or known health conditions. |
format | Online Article Text |
id | pubmed-9601263 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96012632022-10-27 Direct Detection of Glycated Human Serum Albumin and Hyperglycosylated IgG3 in Serum, by MALDI-ToF Mass Spectrometry, as a Predictor of COVID-19 Severity Iles, Ray K. Iles, Jason K. Lacey, Jonathan Gardiner, Anna Zmuidinaite, Raminta Diagnostics (Basel) Article The prefusion spike protein of SARS-CoV-2 binds advanced glycation end product (AGE)-glycated human serum albumin (HSA) and a higher mass (hyperglycosylated/glycated) immunoglobulin (Ig) G3, as determined by matrix assisted laser desorption mass spectrometry (MALDI-ToF). We set out to investigate if the total blood plasma of patients who had recovered from acute respiratory distress syndrome (ARDS) as a result of COVID-19, contained more glycated HSA and higher mass (glycosylated/glycated) IgG3 than those with only clinically mild or asymptomatic infections. A direct serum dilution, and disulphide bond reduction, method was developed and applied to plasma samples from SARS-CoV-2 seronegative (n = 30) and seropositive (n = 31) healthcare workers (HCWs) and 38 convalescent plasma samples from patients who had been admitted with acute respiratory distress (ARDS) associated with COVID-19. Patients recovering from COVID-19 ARDS had significantly higher mass AGE-glycated HSA and higher mass IgG3 levels. This would indicate that increased levels and/or ratios of hyper-glycosylation (probably terminal sialic acid) IgG3 and AGE glycated HSA may be predisposition markers for the development of COVID-19 ARDS as a result of SARS-CoV2 infection. Furthermore, rapid direct analysis of serum/plasma samples by MALDI-ToF for such humoral immune correlates of COVID-19 presents a feasible screening technology for the most at risk; regardless of age or known health conditions. MDPI 2022-10-17 /pmc/articles/PMC9601263/ /pubmed/36292212 http://dx.doi.org/10.3390/diagnostics12102521 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Iles, Ray K. Iles, Jason K. Lacey, Jonathan Gardiner, Anna Zmuidinaite, Raminta Direct Detection of Glycated Human Serum Albumin and Hyperglycosylated IgG3 in Serum, by MALDI-ToF Mass Spectrometry, as a Predictor of COVID-19 Severity |
title | Direct Detection of Glycated Human Serum Albumin and Hyperglycosylated IgG3 in Serum, by MALDI-ToF Mass Spectrometry, as a Predictor of COVID-19 Severity |
title_full | Direct Detection of Glycated Human Serum Albumin and Hyperglycosylated IgG3 in Serum, by MALDI-ToF Mass Spectrometry, as a Predictor of COVID-19 Severity |
title_fullStr | Direct Detection of Glycated Human Serum Albumin and Hyperglycosylated IgG3 in Serum, by MALDI-ToF Mass Spectrometry, as a Predictor of COVID-19 Severity |
title_full_unstemmed | Direct Detection of Glycated Human Serum Albumin and Hyperglycosylated IgG3 in Serum, by MALDI-ToF Mass Spectrometry, as a Predictor of COVID-19 Severity |
title_short | Direct Detection of Glycated Human Serum Albumin and Hyperglycosylated IgG3 in Serum, by MALDI-ToF Mass Spectrometry, as a Predictor of COVID-19 Severity |
title_sort | direct detection of glycated human serum albumin and hyperglycosylated igg3 in serum, by maldi-tof mass spectrometry, as a predictor of covid-19 severity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601263/ https://www.ncbi.nlm.nih.gov/pubmed/36292212 http://dx.doi.org/10.3390/diagnostics12102521 |
work_keys_str_mv | AT ilesrayk directdetectionofglycatedhumanserumalbuminandhyperglycosylatedigg3inserumbymalditofmassspectrometryasapredictorofcovid19severity AT ilesjasonk directdetectionofglycatedhumanserumalbuminandhyperglycosylatedigg3inserumbymalditofmassspectrometryasapredictorofcovid19severity AT laceyjonathan directdetectionofglycatedhumanserumalbuminandhyperglycosylatedigg3inserumbymalditofmassspectrometryasapredictorofcovid19severity AT gardineranna directdetectionofglycatedhumanserumalbuminandhyperglycosylatedigg3inserumbymalditofmassspectrometryasapredictorofcovid19severity AT zmuidinaiteraminta directdetectionofglycatedhumanserumalbuminandhyperglycosylatedigg3inserumbymalditofmassspectrometryasapredictorofcovid19severity |